Citation: Dg. Daniel et al., Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial, PSYCHOPHAR, 155(2), 2001, pp. 128-134
Authors:
Basile, VS
Ozdemir, V
Masellis, M
Meltzer, HY
Lieberman, JA
Potkin, SG
Macciardi, FM
Petronis, A
Kennedy, JL
Citation: Vs. Basile et al., Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia, MOL PSYCHI, 6(2), 2001, pp. 230-234
Authors:
Cahill, L
Haier, RJ
White, NS
Fallon, J
Kilpatrick, L
Lawrence, C
Potkin, SG
Alkire, MT
Citation: L. Cahill et al., Sex-related difference in amygdala activity during emotionally influenced memory storage, NEUROBIOL L, 75(1), 2001, pp. 1-9
Authors:
Kojima, T
Matsushima, E
Ohta, K
Toru, M
Han, YH
Shen, YC
Moussaoui, D
David, I
Sato, K
Yamashita, I
Kathmann, N
Hippius, H
Thavundayil, JX
Lal, S
Nair, NPV
Potkin, SG
Prilipko, L
Citation: T. Kojima et al., Stability of exploratory eye movements as a marker of schizophrenia - a WHO multi-center study, SCHIZOPHR R, 52(3), 2001, pp. 203-213
Authors:
Potkin, SG
Fleming, K
Jin, Y
Gulasekaram, B
Citation: Sg. Potkin et al., Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics, J CL PSYCH, 21(5), 2001, pp. 479-483
Authors:
Fleming, K
Thyrum, P
Yeh, C
Vargo, DL
Potkin, SG
Citation: K. Fleming et al., Cognitive improvements in psychotic subjects treated with "Seroquel" (quetiapine fumarate): An exploratory study, J CL PSYCH, 21(5), 2001, pp. 527-529
Authors:
Asnis, GM
Hameedi, FA
Goddard, AW
Potkin, SG
Black, D
Jameel, M
Desagani, K
Woods, SW
Citation: Gm. Asnis et al., Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients, PSYCHIAT R, 103(1), 2001, pp. 1-14
Authors:
Basile, VS
Ozdemir, V
Masellis, M
Walker, ML
Heltzer, HY
Lieberman, JA
Potkin, SG
Alva, G
Kalow, W
Macciardi, FM
Kennedy, JL
Citation: Vs. Basile et al., A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia, MOL PSYCHI, 5(4), 2000, pp. 410-417
Authors:
Jin, Y
Castellanos, A
Solis, ER
Potkin, SG
Citation: Y. Jin et al., EEG resonant responses in schizophrenia: a photic driving study with improved harmonic resolution, SCHIZOPHR R, 44(3), 2000, pp. 213-220
Authors:
Vincent, JB
Neves-Pereira, ML
Paterson, AD
Yamamoto, E
Parikh, SV
Macciardi, F
Gurling, HMD
Potkin, SG
Pato, CN
Macedo, A
Kovacs, M
Davies, M
Lieberman, JA
Meltzer, HY
Petronis, A
Kennedy, JL
Citation: Jb. Vincent et al., An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: A common expansion lotus, AM J HU GEN, 66(3), 2000, pp. 819-829
Authors:
Basile, VS
Masellis, M
Badri, F
Paterson, AD
Meltzer, HY
Lieberman, JA
Potkin, SG
Macciardi, F
Kennedy, JL
Citation: Vs. Basile et al., Association of the MscI polymorphism of the dopamine D3 receptor gene withtardive dyskinesia in schizophrenia, NEUROPSYCH, 21(1), 1999, pp. 17-27
Authors:
Daniel, DG
Zimbroff, DL
Potkin, SG
Reeves, KR
Harrigan, EP
Lakshminarayanan, M
Citation: Dg. Daniel et al., Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial, NEUROPSYCH, 20(5), 1999, pp. 491-505
Authors:
Potkin, SG
Jin, Y
Bunney, BG
Costa, J
Gulasekaram, B
Citation: Sg. Potkin et al., Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia, AM J PSYCHI, 156(1), 1999, pp. 145-147
Authors:
Huntsman, MM
Tran, BV
Potkin, SG
Bunney, WE
Jones, EG
Citation: Mm. Huntsman et al., Altered ratios of alternatively spliced long and short gamma 2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics, P NAS US, 95(25), 1998, pp. 15066-15071